{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:46Z","timestamp":1791685426284,"version":"4.3.4"},"reference-count":94,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K022202"],"award-info":[{"award-number":["MR\/K022202"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Ebselen is an organoselenium compound developed as an antioxidant and subsequently shown to be a glutathione peroxidase (GPx) mimetic. Ebselen shows some efficacy in post-stroke neuroprotection and is currently in trial for the treatment and prevention of hearing loss, Meniere\u2019s Disease and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In vitro screening studies show that ebselen is also an effective inhibitor of the enzyme inositol monophosphatase (IMPase), which is a key target of the mood-stabilising drug lithium. Further, in animal experimental studies, ebselen produces effects on the serotonin system very similar to those of lithium and also decreases behavioural impulsivity. The antidepressant effects of lithium in treatment-resistant depression (TRD) have been attributed to its ability to facilitate presynaptic serotonin activity; this suggests that ebselen might also have a therapeutic role in this condition. Human studies utilising magnetic resonance spectroscopy support the notion that ebselen, at therapeutic doses, inhibits IMPase in the human brain. Moreover, neuropsychological studies support an antidepressant profile for ebselen based on positive effects on emotional processing and reward seeking. Ebselen also lowers a human laboratory measure of impulsivity, a property that has been associated with lithium\u2019s anti-suicidal effects in patients with mood disorders. Current clinical studies are directed towards assessment of the neuropsychological effects of ebselen in TRD patients. It will also be important to ascertain whether ebselen is able to lower impulsivity and suicidal behaviour in clinical populations. The objective of this review is to summarise the developmental history, pre-clinical and clinical psychopharmacological properties of ebselen in psychiatric disorders and its potential application as a treatment for TRD.<\/jats:p>","DOI":"10.3390\/ph15040485","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T01:03:01Z","timestamp":1650330181000},"page":"485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Potential Use of Ebselen in Treatment-Resistant Depression"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-7616","authenticated-orcid":false,"given":"Fitri Fareez","family":"Ramli","sequence":"first","affiliation":[{"name":"Clinical Psychopharmacology Research Group, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK"},{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Cowen","sequence":"additional","affiliation":[{"name":"Clinical Psychopharmacology Research Group, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-3765","authenticated-orcid":false,"given":"Beata R.","family":"Godlewska","sequence":"additional","affiliation":[{"name":"Clinical Psychopharmacology Research Group, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2017). Depression and Other Common Mental Disorders: Global Health Estimates, World Health Organization."},{"key":"ref_2","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789\u20131858."},{"key":"ref_3","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet, 398, 1700\u20131712."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of Treatment-Resistant Depression: Challenges and Strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1017\/S003329171700068X","article-title":"Backing into the future: Pharmacological approaches to the management of resistant depression","volume":"47","author":"Cowen","year":"2017","journal-title":"Psychol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22630","article-title":"Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: The MIR RCT","volume":"22","author":"Kessler","year":"2018","journal-title":"Health Technol. Assess."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.focus.140202","article-title":"Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes","volume":"14","author":"Spielmans","year":"2016","journal-title":"Focus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2014.05.053","article-title":"A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression","volume":"168","author":"Nelson","year":"2014","journal-title":"J. Affect. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/02698811211013579","article-title":"Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium","volume":"35","author":"Bahji","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: A systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","article-title":"A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0092-8674(89)90026-3","article-title":"Neural and developmental actions of lithium: A unifying hypothesis","volume":"59","author":"Berridge","year":"1989","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1042\/BST0371121","article-title":"Knockout mice in understanding the mechanism of action of lithium","volume":"37","author":"Agam","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bcp.2013.08.028","article-title":"The early research and development of ebselen","volume":"86","author":"Parnham","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/jo00273a035","article-title":"Expedient synthesis of ebselen and related compounds","volume":"54","author":"Engman","year":"1989","journal-title":"J. Org. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Santi, C., Scimmi, C., and Sancineto, L. (2021). Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation. Molecules, 26.","DOI":"10.3390\/molecules26144230"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2015.05.002","article-title":"Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation","volume":"97","author":"Shaaban","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/0006-2952(84)90084-4","article-title":"A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase","volume":"33","author":"Wendel","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0891-5849(93)90028-S","article-title":"Ebselen, a selenoorganic compound as glutathione peroxidase mimic","volume":"14","author":"Sies","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3940(94)11226-9","article-title":"The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat","volume":"185","author":"Dawson","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_23","first-page":"239","article-title":"Effects of ebselen (PZ51) on ischaemic brain oedema after focal ischaemia in cats","volume":"51","author":"Johshita","year":"1990","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006123-199802000-00038","article-title":"Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Saito","year":"1998","journal-title":"Neurosurgery"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: A placebo-controlled, double-blind clinical trial. Ebselen Study Group","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1007\/s00213-020-05654-1","article-title":"A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania","volume":"237","author":"Sharpley","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/bph.14179","article-title":"Ebselen has lithium-like effects on central 5-HT(2A) receptor function","volume":"175","author":"Antoniadou","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpsychires.2018.11.021","article-title":"A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer\u2019s disease","volume":"109","author":"Martini","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00775-017-1463-2","article-title":"Ebselen ameliorates \u03b2-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer\u2019s disease mice","volume":"22","author":"Xie","year":"2017","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_30","first-page":"1412","article-title":"Ebselen protects rat hearts against myocardial ischemia-reperfusion injury","volume":"17","author":"Cheng","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.freeradbiomed.2020.06.032","article-title":"Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections","volume":"156","author":"Sies","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(17)31791-9","article-title":"Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"390","author":"Kil","year":"2017","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lynch, E., and Kil, J. (2009). Development of ebselen, a glutathione peroxidase mimic, for the prevention and treatment of noise-induced hearing loss. Proceedings of Seminars in Hearing, Thieme Medical Publishers.","DOI":"10.1055\/s-0028-1111106"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108209","DOI":"10.1016\/j.heares.2021.108209","article-title":"Development of ebselen for the treatment of sensorineural hearing loss and tinnitus","volume":"413","author":"Kil","year":"2022","journal-title":"Hear. Res."},{"key":"ref_35","unstructured":"Kil, J., Huang, M., Nguyen, S., Chandrasekhar, S., and Lambert, P. (2018). SPI-1005 A Novel Investigational Drug For The Treatment of Meniere\u2019s Disease. Proceedings of 2018 ARO Abstract, Association for Research in Otolaryngology."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eabd0345","DOI":"10.1126\/sciadv.abd0345","article-title":"Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease","volume":"6","author":"Alvarado","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104889","DOI":"10.1016\/j.bioorg.2021.104889","article-title":"Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals","volume":"112","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00213-015-4189-2","article-title":"Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: A magnetic resonance spectroscopy study at 7 tesla","volume":"233","author":"Masaki","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/npp.2015.343","article-title":"Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans","volume":"41","author":"Singh","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_40","first-page":"537279","article-title":"Cytotoxicity and genotoxicity evaluation of organochalcogens in human leucocytes: A comparative study between ebselen, diphenyl diselenide, and diphenyl ditelluride","volume":"2013","author":"Meinerz","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/10715762.2018.1536824","article-title":"Toxicity of organochalcogens in human leukocytes is associated, but not directly related with reactive species production, apoptosis and changes in antioxidant gene expression","volume":"52","author":"Bueno","year":"2018","journal-title":"Free Radic. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-4274(03)00090-0","article-title":"Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice","volume":"143","author":"Meotti","year":"2003","journal-title":"Toxicol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.toxlet.2003.10.001","article-title":"Additive pro-oxidative effects of methylmercury and ebselen in liver from suckling rat pups","volume":"146","author":"Farina","year":"2004","journal-title":"Toxicol. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfq185","article-title":"Mitochondrial dysfunction induced by different organochalchogens is mediated by thiol oxidation and is not dependent of the classical mitochondrial permeability transition pore opening","volume":"117","author":"Puntel","year":"2010","journal-title":"Toxicol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tiv.2012.10.011","article-title":"Mitochondrial electron transfer chain complexes inhibition by different organochalcogens","volume":"27","author":"Puntel","year":"2013","journal-title":"Toxicol. Vitr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ncomms2320","article-title":"A safe lithium mimetic for bipolar disorder","volume":"4","author":"Singh","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1107\/S2053230X20011310","article-title":"Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase","volume":"76","author":"Fenn","year":"2020","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4001618","article-title":"Lithium and bipolar mood disorder: The inositol-depletion hypothesis revisited","volume":"10","author":"Harwood","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2008.10.055","article-title":"Antidepressant-like effect of the organoselenium compound ebselen in mice: Evidence for the involvement of the monoaminergic system","volume":"602","author":"Posser","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000118046","article-title":"Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses","volume":"11","author":"Lerer","year":"1984","journal-title":"Neuropsychobiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291700009132","article-title":"Dextroamphetamine-induced arousal in human subjects as a model for mania","volume":"16","author":"Jacobs","year":"1986","journal-title":"Psychol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2019.01.006","article-title":"Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs","volume":"362","author":"Lan","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/wps.20229","article-title":"What has serotonin to do with depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(85)90344-9","article-title":"Short-term lithium administration enhances serotonergic neurotransmission: Electrophysiological evidence in the rat CNS","volume":"113","author":"Blier","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00442813","article-title":"Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression","volume":"99","author":"Cowen","year":"1989","journal-title":"Psychopharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0028-3908(91)90111-N","article-title":"Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro","volume":"30","author":"Sharp","year":"1991","journal-title":"Neuropharmacology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00213-002-1341-6","article-title":"Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: Neurochemical and behavioural studies in the rat","volume":"166","author":"Wegener","year":"2003","journal-title":"Psychopharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00174065","article-title":"Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2-adrenoceptor mediated function in mice","volume":"90","author":"Goodwin","year":"1986","journal-title":"Psychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuropharm.2005.11.020","article-title":"Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis","volume":"50","author":"Boothman","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref_61","first-page":"215P","article-title":"Effect of ebselen, a putative lithium mimetic, on central 5-HT2C receptor function in the mouse","volume":"1","author":"Antoniadou","year":"2015","journal-title":"Proc. Br. Pharmacol. Soc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2009.03.016","article-title":"Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects","volume":"57","author":"Sotty","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/ADM.0000000000000574","article-title":"Pharmacological and Psychosocial Treatment of Adults With Gambling Disorder: A Meta-Review","volume":"14","author":"Remondi","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/npp.2015.46","article-title":"Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System","volume":"40","author":"Fink","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0269881118784876","article-title":"The putative lithium-mimetic ebselen reduces impulsivity in rodent models","volume":"32","author":"Barkus","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","article-title":"Ebselen, a promising antioxidant drug: Mechanisms of action and targets of biological pathways","volume":"41","author":"Azad","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1016\/j.bmcl.2006.07.085","article-title":"Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds","volume":"16","author":"Mishra","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-2952(92)90035-H","article-title":"Action of ebselen as an antioxidant against lipid peroxidation","volume":"44","author":"Noguchi","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11033-020-05326-5","article-title":"Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer\u2019s disease","volume":"47","author":"Klann","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1093\/schbul\/sby016.496","article-title":"T220. The glutaminase inhibitor ebselen prevents amphetamine sensitization in mice","volume":"44","author":"Lander","year":"2018","journal-title":"Schizophr. Bull."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2013.07.014","article-title":"In vitro glutathione peroxidase mimicry of ebselen is linked to its oxidation of critical thiols on key cerebral suphydryl proteins-A novel component of its GPx-mimic antioxidant mechanism emerging from its thiol-modulated toxicology and pharmacology","volume":"206","author":"Kade","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00204-011-0720-3","article-title":"Toxicology and pharmacology of selenium: Emphasis on synthetic organoselenium compounds","volume":"85","author":"Nogueira","year":"2011","journal-title":"Arch. Toxicol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","article-title":"Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment","volume":"238","author":"Godlewska","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00213-016-4319-5","article-title":"Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing","volume":"233","author":"Masaki","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-011-2496-9","article-title":"Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats","volume":"219","author":"Ohmura","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.133.12.1409","article-title":"The effect of lithium on impulsive aggressive behavior in man","volume":"133","author":"Sheard","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S0033291701003804","article-title":"Decision-making cognition in mania and depression","volume":"31","author":"Murphy","year":"2001","journal-title":"Psychol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-3223(94)00135-P","article-title":"Effect of pharmacologic treatments on the sleep of depressed patients","volume":"37","author":"Sharpley","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00442020","article-title":"Lithium increases slow wave sleep: Possible mediation by brain 5-HT2 receptors?","volume":"98","author":"Friston","year":"1989","journal-title":"Psychopharmacology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ijnp\/pyy094","article-title":"Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments","volume":"22","author":"Kadriu","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbrc.2013.06.110","article-title":"Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors","volume":"438","author":"Thomas","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.118.252635","article-title":"In Vivo Preclinical Molecular Imaging of Repeated Exposure to an N-methyl-d-aspartate Antagonist and a Glutaminase Inhibitor as Potential Glutamatergic Modulators","volume":"368","author":"Servaes","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e22151","DOI":"10.1002\/syn.22151","article-title":"Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmission","volume":"74","author":"Mota","year":"2020","journal-title":"Synapse"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1014903127672","article-title":"Exposure to ebselen changes glutamate uptake and release by rat brain synaptosomes","volume":"27","author":"Nogueira","year":"2002","journal-title":"Neurochem. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3940(01)01519-1","article-title":"Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons","volume":"299","author":"Rocha","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","article-title":"Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: A meta-analysis","volume":"14","author":"Gigante","year":"2012","journal-title":"Bipolar Disord."},{"key":"ref_90","first-page":"708","article-title":"Effects of ebselen on glutathione level in neurons exposed to arachidonic acid and 4-hydroxynonenal during simulated ischemia in vitro","volume":"59","author":"Pawlas","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neures.2006.01.002","article-title":"Contribution of reduced and oxidized glutathione to signals detected by magnetic resonance spectroscopy as indicators of local brain redox state","volume":"55","author":"Satoh","year":"2006","journal-title":"Neurosci. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2008.05.001","article-title":"Glutathione: A novel treatment target in psychiatry","volume":"29","author":"Berk","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pharmthera.2018.12.010","article-title":"Cognitive neuropsychological theory: Reconciliation of psychological and biological approaches for depression","volume":"197","author":"Godlewska","year":"2019","journal-title":"Pharmacol. Ther."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:55:19Z","timestamp":1760136919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":94,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ph15040485"],"URL":"https:\/\/doi.org\/10.3390\/ph15040485","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]}}}